Brief: Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results And Provides Business Update

Fennec Pharmaceuticals

12/05/2022 11:11

May 12 (Reuters) - Fennec Pharmaceuticals Inc  FENC.O :
    * FENNEC PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q1 LOSS PER SHARE $0.14
    * CASH AND CASH EQUIVALENTS WERE $18.3 MILLION AS OF MARCH
31,
2022
    * FDA PRESCRIPTION DRUG USER FEE ACT (PDUFA) TARGET ACTION
DATE
SET FOR SEPTEMBER 23, 2022 FOR PEDMARK

Source text for Eikon:  ID:nGNX1cxSkt 
Further company coverage:  FENC.O 

 ((Reuters.Briefs@thomsonreuters.com;))